You are here: Industry Insights > Immunogenicity

News List

Immunogenicity Information in Labeling FDA
March 25, 2022
This webinar has been approved for 1.5 contact hours of continuing education for pharmacists, physicians, and nurses. Please see detailed announcement for additional information.
BioGenes and FyoniBio Combine Their Scientific Expertise and Cooperate on Pharmacokinetic and Immunogenicity Analyses b3cnewswire
August 25, 2021
Pharmacokinetic and immunogenicity projects can be both diverse and complex, involving work packages from antibody generation and production to the analysis of clinical samples with validated assays.
Nexelis to Acquire ImmunXperts contractpharma
March 06, 2020
Nexelis, a portfolio company of Ampersand Capital Partners, and a provider of assay development and advanced laboratory testing has signed a definitive agreement to acquire ImmunXperts.
Krystal Biotech Completes Construction of New GMP Facility americanpharmaceuticalreview
January 16, 2019
Krystal Biotech announced construction of Ancoris, a new state-of-the-art Good Manufacturing Practice (GMP) facility, is complete...
Panacea initiates Phase I prostate cancer vaccine therapy trial europeanpharmaceuticalreview
January 20, 2017
Panacea Pharmaceuticals have enrolled and dosed the first patient in the open-label, parallel designed, multi-centre Phase I clinical trial of PAN-301-1, for the treatment of persistent prostate cancer to assess safety and immunogenicity.